Scientific American Talks The Rise of Cryptocurrency
Jen Schwartz, senior editor and blockchain expert at Scientific American, talks the magazine's latest articles on the rise of Bitcoin and what impact cryptocurrencies may have on our future.
Schwartz digs into how what people currently love about cryptocurrency could be seen as a threat in the future. One of the positives of cryptocurrency is its lack of centralization and regulation. But if entire countries begin to use it as their national currency, everything citizens purchase will be seen by the government.
Schwartz digs into some of the biggest questions around the rise of Bitcoin today - how will it benefit everyday people in the long-term? What happens if the bubble bursts, and what will that do for investor trust in cryptocurrency?
Schwartz gives her advice for people looking to possibly invest in Bitcoin, adding that if you are not concerned with losing money and you're looking to experiment, make the investment. If risk is a big concern for you, investing in crypto right now may not be the right move.
Virgin Galactic is reporting an increase in demand for commercial space flights after seeing a boost in ticket sales, raising the price for a seat on a shuttle to $450,000. The company said they now have 700 customers.
Walmart has joined forces with robotruck start-up Gatik to deploy driverless grocery delivery. We spoke to the CEO and co-founder of Gatik to discuss how the technology works and how autonomous vehicles will help ease supply chain issues.
At least 7 million customers have been impacted by a data breach on the investing app Robinhood. The specific information that was leaked varied by each customer, but Robinhood stated that hackers did not access social security numbers or banking information.
Paulina Likos, Investing Reporter at US News & World report, joined Wake Up With Cheddar to break down how the U.S. reopening its borders to foreign travelers might provide a big boost to the hard-hit travel and tourism industry.
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Doug Astrop, managing partner at Exponential Investment Partners, joined Cheddar to discuss Peloton's precipitous price drop, and whether the company can recover as the at-home workout trend tapers off. "They've lowered the prices on their equipment to try to attract a bigger audience because ultimately they're sort of headed to this Apple ecosystem model where they can monetize a loyal customer base," he said. Astrop noted that he believes there is a reality where the in-person gym experience and Peloton's at-home programs can co-exist.
Bill Stone, Chief Investment Officer at Glenview Trust Company, joined Wake Up With Cheddar to break down markets headlines ahead of the start of the trading week.
Jill and Carlo discuss the scenes of joy at American airports as borders reopen, another tool in the Covid toolbox, the latest in the Astroworld crowd crush tragedy and more.
